Skip to content
Sen. Todd Young (R-IN) was recently named Chair of the National Security Commission on Emerging Biotechnology (NSCEB), established by Congress to recommend policy on biotech and national security. […]
A new suite of rules governing drug rebates in Medicaid has been finalized, removing months of uncertainty about whether the Centers for Medicare and
Voters want to bolster American manufacturing across biopharmaceutical and biotechnology sectors, according to a new public opinion survey conducted by Morning Consult for the
New survey checks pulse on voters’ concerns for innovation and biomanufacturing Read More »
Drug price controls in the Inflation Reduction Act (IRA) involve unconstitutional coercion and will destroy innovation in transformational treatments that save patients’ lives, the
BIO files amicus brief challenging IRA drug price controls Read More »
The heads of the three largest pharmacy benefit managers (PBMs) were grilled on July 23 by the House Oversight and Accountability Committee, whose new
House Oversight Committee grills PBM executives over ‘despicable’ practices Read More »
The House Ways and Means Committee learned how lawmakers can enable progress in biotech from a Biotechnology Innovation Organization (BIO) Board member and the
BIO Board member and head of BioUtah testify at House field hearing Read More »
“ALS is a devastating disease.” This is a common refrain when talking about Amyotrophic Lateral Sclerosis (ALS), a nervous system disease that weakens muscles
Unlocking hope: AMP ALS is transforming ALS biomarker research Read More »
In implementing the Inflation Reduction Act (IRA), the Centers for Medicare and Medicaid Services (CMS) has made efforts to unnecessarily broaden the law with
CMS overreach will impede innovation Read More »
Biopharma supply chains, streamlining regulation, and other critical issues came up when the leader of the U.S. agency regulating drugs spoke with the leader
FDA’s Dr. Califf talks supply chains, clinical trial diversity, and America’s health Read More »
“Biotechnology, that’s a great, big word that just means hope.” That’s what Christopher Reeve said years ago at a BIO International Convention. Little did
Admiral William H. McRaven and BIO CEO John F. Crowley talk hope in biotech Read More »
